Cargando…

Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome

22q11 Deletion Syndrome (22q11DS) is associated with dysmorphology and a high prevalence of schizophrenia-like symptoms. Several genes located on chromosome 22q11 have been linked to schizophrenia. The deletion is thought to disrupt the expression of multiple genes involved in maturation and develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Beveren, Nico J. M., Krab, Lianne C., Swagemakers, Sigrid, Buitendijk, Gabriella, Boot, Erik, van der Spek, Peter, Elgersma, Ype, van Amelsvoort, Therese A. M. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310870/ https://www.ncbi.nlm.nih.gov/pubmed/22457764 http://dx.doi.org/10.1371/journal.pone.0033473

Ejemplares similares

Correction: Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome
por: van Beveren, Nico J. M., et al.
Publicado: (2012)

Marked Reduction of AKT1 Expression and Deregulation of AKT1-Associated Pathways in Peripheral Blood Mononuclear Cells of Schizophrenia Patients
por: van Beveren, Nico J. M., et al.
Publicado: (2012)

Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders
por: Ottenhoff, Myrthe J., et al.
Publicado: (2020)

Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review
por: de Boer, Janna, et al.
Publicado: (2019)

Post-traumatic stress in adults with 22q11.2 deletion syndrome
por: von Scheibler, Emma N. M. M., et al.
Publicado: (2022)

Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome
por: da Silva Alves, Fabiana, et al.
Publicado: (2011)

Correction: Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome
por: da Silva Alves, Fabiana, et al.
Publicado: (2011)

Motor Learning in Children with Neurofibromatosis Type I
por: Krab, Lianne C., et al.
Publicado: (2010)

Environmental Influences on the Relation between the 22q11.2 Deletion Syndrome and Mental Health: A Literature Review
por: Snihirova, Yelyzaveta, et al.
Publicado: (2022)

Neural correlates of reward processing in adults with 22q11 deletion syndrome
por: van Duin, Esther D. A., et al.
Publicado: (2016)

Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome
por: Shin, Woosub, et al.
Publicado: (2023)

Erratum to: Neural correlates of reward processing in adults with 22q11 deletion syndrome
por: Van Duin, Esther D. A., et al.
Publicado: (2016)

Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome
por: Evers, Laurens J. M., et al.
Publicado: (2015)

Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study
por: von Scheibler, Emma N. M. M., et al.
Publicado: (2021)

A Visual Metaphor Describing Neural Dynamics in Schizophrenia
por: van Beveren, Nico J. M., et al.
Publicado: (2008)

F72. NEUROCOGNITION AND ADAPTIVE FUNCTIONING IN THE 22Q11.2 DELETION SYNDROME MODEL OF SCHIZOPHRENIA
por: Ania, Fiksinski, et al.
Publicado: (2018)

Cognitive deficits in childhood, adolescence and adulthood in 22q11.2 deletion syndrome and association with psychopathology
por: Morrison, Sinead, et al.
Publicado: (2020)

T173. GABA AND GLUTAMATE IN PATIENTS WITH 22Q11.2 DELETION SYNDROME AND HEALTHY VOLUNTEERS AND THE RELATION WITH COGNITION: A RANDOMIZED DOUBLE-BLIND 7TESLA PHARMACOLOGICAL MRS STUDY
por: Vingerhoets, Claudia, et al.
Publicado: (2018)

A mouse model of 22q11.2 deletions: Molecular and behavioral signatures of Parkinson’s disease and schizophrenia
por: Sumitomo, Akiko, et al.
Publicado: (2018)

Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome
por: Bakker, Geor, et al.
Publicado: (2016)

Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study
por: Vingerhoets, Claudia, et al.
Publicado: (2020)

Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion
por: Cleynen, Isabelle, et al.
Publicado: (2020)

Adult Height, 22q11.2 Deletion Extent, and Short Stature in 22q11.2 Deletion Syndrome
por: Heung, Tracy, et al.
Publicado: (2022)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

Schizophrenia and Hereditary Polyneuropathy: PMP22 Deletion as a Common Pathophysiological Link?
por: Endres, Dominique, et al.
Publicado: (2019)

Association between antipsychotic medication and clinically relevant weight change: meta-analysis
por: Campforts, Bea, et al.
Publicado: (2023)

22q11.2 Deletion Syndrome–Associated Parkinson's Disease
por: Boot, Erik, et al.
Publicado: (2018)

The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
por: van Hooijdonk, Carmen F. M., et al.
Publicado: (2022)

Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
por: N Mustafa, Dana A, et al.
Publicado: (2014)

Obesity in adults with 22q11.2 deletion syndrome
por: Voll, S, et al.
Publicado: (2016)

23.3 DEVELOPMENTAL TRAJECTORIES OF SCHIZOPHRENIA-RELEVANT ABNORMALITIES IN A MOUSE MODEL OF 22Q11.2 DELETION SYNDROME
por: Ciampoli, Mariasole, et al.
Publicado: (2018)

All-cause mortality and survival in adults with 22q11.2 deletion syndrome
por: Van, Lily, et al.
Publicado: (2019)

A CDC42 Stop-loss Mutation in a Patient with Relapsing Polychondritis and Autoinflammation
por: van Wijck, Rogier T. A., et al.
Publicado: (2022)

Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
por: Wang, Tiantian, et al.
Publicado: (2018)

A brain proteomic investigation of rapamycin effects in the Tsc1(+/−) mouse model
por: Wesseling, Hendrik, et al.
Publicado: (2017)

Lower [(18)F]fallypride binding to dopamine D(2/3) receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study
por: van Duin, Esther D. A., et al.
Publicado: (2020)

Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What’s the Evidence?
por: Vingerhoets, Wilhelmina A. M., et al.
Publicado: (2013)

Predictive biomarkers for negative symptoms in schizophrenia
por: Cakici, N., et al.
Publicado: (2021)

O4.8. VULNERABLE PERIODS FOR COGNITIVE DEVELOPMENT IN INDIVIDUALS AT HIGH GENOMIC RISK OF SCHIZOPHRENIA
por: Morrison, Sinead, et al.
Publicado: (2018)

White matter microstructure in 22q11 deletion syndrome: a pilot diffusion tensor imaging and voxel-based morphometry study of children and adolescents
por: Sundram, Frederick, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_75h476eub4oo21p7803pju7a8i